A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Can long-acting insulin analogs help overcome the challenge of nocturnal hypoglycemia? On the basis of this review of clinical trial results, insulin detemir or insulin glargine may be the best ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

This human insulin analogue that comes in disposable pens prefilled with 1, 1.5, or 3 mL, dosed in 10-unit increments1 binds reversibly to albumin, which extends its half-life to around 7 days. Steady ...

Today, Plantsulin blends this century-old discovery with modern scientific validation to offer a fast, convenient “whole-body reboot” for maintaining optimal glucose levels. Unlike restrictive diets ...

Various insulin regimens are used to treat patients with type 2 diabetes mellitus that is inadequately controlled by oral antidiabetic therapy. However, few studies have compared insulin regimens.

Insulin icodec is an acylated insulin analogue that makes it bind strongly to albumin in the body and have reduced affinity for insulin receptors, effectively creating an inactive reservoir that ...

Objectives: The prevalence, causes, and consequences of nocturnal hypoglycemia as well as detection and prevention strategies are reviewed, including the use of long-acting insulin analogs ...